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Abstract
This review article discusses the utility of 18F-FDG PET/CT in diagnosis and management of vascular disease. We stress use-
fulness of this method in large vessel inflammation and infection. 
In our work we based on the literature analysis and clinical cases diagnosed in our institution by use of 18F-FDG PET/CT. The 
literature exploration was focusing on vascular inflammation and infections and 18-FDG PET. The search was performed on 
PubMed database and cross referencing.
We present the practical review with several images of vascular diseases like: Takayasu arteritis, giant cell arteritis, vascular graft 
infections, abdominal aortic aneurysm infections and cases of aortitis and periaortitis. From this work inflammation associated 
with atheromatic process and vulnerable atherosclerotic plaque we excluded. 
18F-FGD PET/CT is a sensitive metabolic, reliable, non-invasive imaging modality suitable for diagnosis and follow-up of inflam-
mation and infections in vascular system. 
KEY words: positron emission tomography, fluoro-deoxy-glucose, large vessel vasculitis, vascular graft infections, 
aortitis, periaortitis, abdominal aortic aneurysm infections
Nuclear Med Rev 2016; 19, 1: 28–36
Background
Increase application of positron emission tomography/comput-
ed tomography (PET/CT) with use of 18F-fluoro-2-deoxy-D-glucose 
(18F-FDG) in the diagnosis of inflammatory and infectious dis-
eases is recently observed. As a result of this interest, combine 
guidelines of the European Association of Nuclear Medicine (EANM) 
and the Society of Nuclear Medicine and Molecular Imaging (SN-
MMI) were published in 2013 [1]. 
18F-FDG primarily was proposed in oncologic PET/CT. 
18F-FGD as glucose analogue is taken up by viable cells using 
membrane glucose transporter proteins (GLUT) and subsequently 
is phosphorylated by hexokinase. During routine imaging of cancer 
patients, accumulation of 18F-FDG was observed at sites of inflam-
mation/infection. Inflammatory cells involved in that reaction — like 
monocytes and neutrophils — are also able to overexpress GLUT 1 
and GLUT 3 and have high activity of hexokinase. This ability pre-
dominantly depends on glycolytic activity of these cells and is based 
on the phenomenon that granulocytes, essentially neutrophils and 
monocytes, use glucose as an energy source only after activa-
tion during the metabolic burst [1, 2]. Thus, the accumulation of 
18F-FDG in activated inflammatory cells enables the imaging of 
inflammation and infections. Hence, 18F-FDG PET/CT is desig-
nated for diagnosis of various inflammatory and infectious diseases, 
such as: sarcoidosis, inflammatory bowel disease, osteomyelitis, 
spondylodiscitis, fever of unknown origin (FUO), primary evalua-
tion of vasculitides, vascular prostheses infection, and infection of 
intravascular devices, pacemakers and catheters [1]. Additionally, 
the hybrid approach of FDG PET/CT gives an complementary infor-
mation about inflammatory or infectious — increased FDG uptake 
is seen mainly in active processes, whereas CT provides information 
of the advance stages, for example calcification in chronic or past 
inflammation [3]. To avoid false positive results in vascular diseas-
es evaluation, one should be aware that in physiological conditions, 
large arteries like: aorta, iliac and femoral, subclavian and carotid 
arteries, present homogeneously increased activity of FDG. Arterial 
wall activity increases with age and also in patients with hypertension 
and hyperlipidemia. Increased arteries activity of FDG has been 
reported in 31–59% of cancer patients over 50 years of age [3]. 
This review is based on the literature analysis and clinical 
cases diagnosed at our institution by use of 18F-FDG PET/CT. The 
literature exploration was focused on vascular inflammation and 
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infections and 18-FDG PET. The literature search was performed on 
PubMed database by use of the combination of “FDG”, “vasculitis”, 
“vascular infection”, “vascular graft infection” and “aortitis”. The 
manual cross referencing were also done.
This review pays special attention to the utility of FDG PET/CT in 
diagnosis and management of inflammatory and infections vascular 
diseases. From this work we excluded inflammation associated 
with atheromatic process and vulnerable atherosclerotic plaque. 
All images presented in this paper were obtained in Chair 
and Department of Nuclear Medicine Medical University of Lublin. 
They were prepared using PET/CT system Biograph mCT S(64)-4R 
(Siemens, Germany). The majority of patients were sent from Chair 
and Clinic of Vascular Surgery and Angiology Medical University of 
Lublin, after giving written consent. 
Vasculitis
Vasculitis is an inflammation of vessel walls with leukocyte 
infiltration and reactive destruction of mural structures and ad-
jacent tissue. The inflammation site avidly accumulates glucose 
and 18F-FDG. 
As far as etiology is concerned, vasculitis could be classified 
either as infectious or noninfectious. Most forms of noninfectious vas-
culitis are divided according to the vessel size involved. This clas-
sification, as in Chapel-Hill consensus conference, is presented in 
Table 1. The infectious vasculitis can be bacterial (e.g., Salmonella 
or Stphylococcus), luetic (syphilis), mycobacterial (e.g., Mycobarcte-
rium tuberculosis), viral (e.g., HIV), rickettsial as well as fungal (e.g., 
Aspergillus arteritis) [4–6]. 
Although there are sporadic reports on the use of 18F-FDG 
PET in a variety of vasculitides of small and medium size ves-
sels such as polyarteritis nodosa, Churg-Strauss syndrome or 
Wegener’s granulomatosis, this technique is used at present mainly 
in large vessel vasculitis [3, 7]. PET technique due to limited spatial 
resolution is not yet a reliable tool for the assessment of the medium 
and small size-vessel vasculitis. The large vessel vasculitides like: 
Takayasu arteritis, giant cell arteritis and other cases of aortitis and 
periaortitis are of interest with respect to 18F-FDG PET/CT. 
Takayasu arteritis (TA), known also as pulseless disease, is sort 
of rare vascular disease, affecting 2–3 patients per year per million in 
worldwide population, with predilection to young Asian female aged 
15–20 years. This disease is ten times more frequent among fe-
males than males [8]. This necrotizing and obliterative large-vessel 
arteritis is usually treated by a high dose of glucocorticoids. The 
early stage of the disease is manifested by systemic symptoms, 
such as fever, malaise, night sweats, weakness and pain. In 
this stage granulomas and infiltration by mononuclear cells occur 
in the adventitia and media. Manifestation of the late stage, known 
as occlusive or pulseless phase, depends on the territory of arte-
rial occlusion. Commonly, the disease involves abdominal aorta, 
than descending aorta, aortic arch and branch vessels. In the late 
stage calcification and stenosis lead to narrowing and occlusions of 
the involved arteries. Less frequently, inflammatory destruction of 
media, leads to aneurysmal dilatation of arteries. 
The diagnosis of TA is based on clinical symptoms which 
depend on disease activity and the degree of stenosis of involved 
arteries. Markers of inflammation, such as serum C-reactive pro-
tein (CRP) and erythrocyte sedimentation rate (ESR) levels as well 
as 18F-FDG PET/CT help to assess the disease activity. Fig-
ure 1 shows the case of young boy, who presented with unspecific 
symptoms like fever, malaise, weight lost, weakness, anemia. He 
was sent to our institution as FUO, but he was actually in the acute 
phase of TA. His carotid arteries were also involved and hypometa-
bolic regions in the brain were seen. 
18F-FDG PET/CT can be helpful in assessment of disease 
activity before treatment as well as to monitor therapeutic effect 
or to detect relapse of the disease despite the therapy [9]. An ex-
ample of active phase of TA before treatment and 6 months after 
glucocorticoids treatment with some normalization of wall vessel 
activity is shown in Figure 2. In the active phase of TA high uptake of 
18F-FDG in PET/CT study is observed, whereas in inactive disease 
Figure 1. Takayasu arteritis in a 14-year-old boy who was referred due 
to fever of unknown origin. He presented weight loss, weakness and 
anemia. The symptoms occurred two months before the examination. 
18F-FDG PET/CT findings: high uptake of FDG in the ascending aorta 
(yellow arrow) and in both common carotid arteries (white arrows)
Table 1. Classification of non-infectious vasculitis
Size of vessels Type of vasculitis
Large vessels Takayasu’s arteritis
Giant cell arteritis
Medium vessels Periarteritis nodosa
Kawasaki’s arteritis
Primary CNS vasculitis
Thrombangitis obliterans (Buerger’s disease)
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this uptake is decreased. The estimation of biodistribution of FDG 
is based on visual assessment or/and semiquantitative analysis, 
for example by evaluation of maximum standardized uptake value 
(SUV max). 
Tezuka et al. proposed the cutoff values for active TA SUV 
max ≥ 2.1, CRP > 0.2 mg/dl and ESR ≥ 19 mm/h [9]. They ob-
served rising of SUV max in active phase of disease: in untreated 
patients — to SUV max 2.8 (2.4–3.2) and in patients with relapse 
of treatment — SUV max 2.6 (2.3–3.3). They also recommend 
FDG PET to monitor the effects of the treatment. Different cutoff 
SUV values were proposed by Kobayashi et al., where SUV > 1.3 
indicates active vasculitis in TA [10]. 
Aortic wall thickening in contrast enhanced CT, described in 
the early stage of TA, is typically presented as so-called “double 
ring” [11]. In chronic cases of TA, arterial calcification is observed 
after 5 years or more. In magnetic resonance (MR) imaging early 
wall thickening can be depicted as well as mural edema. Both 
CT and MR show stenosis, mural thrombi, thickening of aortic 
valves cusp and peripheral effusion [12–14]. 
In contrast to TA, giant cell arteritis (GCA) is common in Cauca-
sian population, with incidence of 18 per 100,000 habitants. Women 
over 50 years of age (female:male; 2:1) are particularly affected [15]. 
Etiology of GCA remains unknown. The most typical symptoms are: 
headache in two thirds of patients and polymyalgia rheumatica in 
half of cases. Myalgia, neck pain, scalp tenderness, jaw claudication, 
fever, transient ischemic attack, fatigue, anorexia, weight lost, and 
night sweats are also frequent [16]. GCA mainly involves the complex 
of intima-media. The acute stage is characterized by granuloma-
tous infiltration, mainly by giant cells and lymphocytes [7]. In chronic 
stage, progressive fibrosis of arterial wall occurs. This arteritis af-
fects usually cranial artery, in particular superficial temporal artery, 
but can involve entire aorta and its branches as well as coronary, 
mesenteric and vertebral arteries. High uptake of FDG in wall of 
affected arteries is usually present (Figure 3). 
The exacerbation of disease is associated with significantly re-
duced 5-year survival [17]. The aortic involvement happens in 15% 
of GCA cases. Moreover, as reported Pacini et al. [18], GCA is the 
most common aortitis and represents 75% of cases of this disease 
in North America. The large vessel vasculitis, particularly GCA, re-
presents up to 17% of fever of unknown origin [19]. 
The diagnosis of GCA is usually based on biopsy of temporal 
artery; however, in case of aortitis, it is not appropriate because 
of the frequent inflammation of the extracranial arteries without 
involvement of the temporal arteries [20]. 
Among various diagnostic modalities, increased role of FDG 
PET has been recently underlined in detection and monitoring of 
GCA. FDG PET has been shown to be sensitive for extracranial 
artery involvement with sensitivity 56%, specificity 98%, positive 
predictive value 93% and negative predictive value 80% [21]. In the 
semiquantitative analysis of aortitis in PET/CT, where images were 
obtained 180 minutes after 18F-FDG administration, the target 
(aortic wall) to background (aortic lumen activity) ratio (TBR) was de-
fined. The TBR index of 1.34 shows very high accuracy (sensitivity 
100% and specificity 94.4%) and is strongly recommended for the 
diagnosis of aortitis in the clinical settings [20].
The limitation of FDG PET in assessment of cranial artery inflam-
mation is low spatial resolution and, therefore, it cannot replace the 
biopsy of the temporal artery [22]. Another limitation of FDG PET 
Figure 2. Takayasu arteritis located mainly in the pulmonary trunk in a 33-year-old male patient. Diagnosis was based on an echocardiography 
and confirmed in contrast enhanced CT. A. 18F-FDG PET/CT examination before treatment. High accumulation of FDG in the pulmonary trunk 
(white arrow) and in the ascending aorta (yellow arrow); B. 18F-FDG PET/CT examination 6 months after treatment, some normalization of vascular 
metabolism in the pulmonary trunk (white arrow) and in the ascending aorta (yellow arrow) is seen (not complete remission). 
A B
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is that vessel activity and SUV should be interpreted with caution 
because of normal blood pool activity and atheromatous changes in 
the vessel wall. It has to be also taken in account that vascular up-
take of FDG increases with age, and in the age of 60 the mean SUV 
can be up to 2.01 ± 0.5 [23]. As Bural et al. conclude, “Increased 
FDG uptake likely represents the presence of active inflammatory 
process of atherosclerotic plaque. The magnitude of inflammation 
within the wall of the large arteries increases with aging” [23].
Inflammation of aortic abdominal aneurysms
By definition, aortic abdominal aneurysm (AAA) is diagnosed 
when infra-renal aortic diameter exceeds 3 cm [24]. Major risk 
factors of AAA include age (≥ 65 years of age), male gender and 
a history of ever smoking (≥ 100 in person’s lifetime) [25]. Most 
dangerous complication of AAA is rupture which is fatal in 70–90% of 
cases and is the13th cause of death in Western countries [26]. There-
fore, prediction of AAA rupture is essential. According to several 
authors [27–29], the strongest risk factor of AAA rupture is maximal 
aortic diameter. Nevertheless, in clinical practice ruptures of small 
AAA also occur and its incidence ranges from 2 to 8% [30, 31]. The 
main role in the small AAA rupture is played by active inflamma-
tory processes, which can be visualized by 18F-FDG PET/CT [32]. 
Figure 4 presents active phase of inflammation of AAA. The inflam-
mation predominantly affects the adventitia and consists of dense 
infiltration of proliferating lymphocytes and phagocytes [33, 34]. 
Matrix metalloproteinases (MMPs) are mainly involved in elastin and 
collagen degradation [35]. The process preceding rupture is con-
nected with high C-reactive protein plasma level, loss of smooth 
muscle cells in the media, collagen and elastin degradation, which 
leads to instability and weakening of aneurysmal wall [32]. High 
uptake of FDG in AAA is associated with clinical symptoms, mostly 
with abdominal pain [36]. 
Recently in the multicenter study by Barwick et al., large 
groups with aneurysms (n = 150) and matching non-aneurysm 
controls (n = 159) were compared. It was found that there was no 
correlation between the size of AAA and the level of activity in the 
aortic wall, as assess by 18F-FDG PET/CT [37].
Vascular graft infection 
Vascular and endovascular surgeries are usually performed in 
highly aseptic conditions, so infection and inflammation in these 
procedures are rare and amount to 0.5–5% of implantations [38]. 
The lowest incidence of inflammation is observed in intra-abdominal 
prostheses, whereas the highest one — in axillo-femoral prosthe-
ses [39]. Vascular graft infection (VGI), however rare, brings very 
severe complications with high morbidity and mortality, ranging 
between 20% and 75% [40, 41]. Factors predisposing to VGI are: 
prolonged preoperative stay, postoperative bacteremia, end-stage 
Figure 3. 18F-FDG PET/CT of a 65-year-old female patient, referred by oncologist with unspecific symptoms and suspicion of lymphoma. 18F-FDG 
PET/CT examination detected high metabolism in large vessels. The final diagnosis — giant cell arthritis. A. High uptake of FDG in the subclavian 
arteries (blue arrows on coronal view), aorta (red arrow on sagittal view), and in the ascending and descending aorta respectively (red and green 
arrows, on axial slice); B. Fused image of 18F-FDG PET/CT coronal, sagittal and axial views
A
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renal disease, obesity, malnutrition/older age, low serum albumin, 
smoking, diabetes mellitus, prior irradiation, autoimmune dis-
ease/corticosteroid therapy, malignancy and chemotherapy [39]. 
The clinical manifestation of VGI may occur long after surgery; often 
may be unspecific and subtle. 
Because of high-risk associated with reoperation, it is necessary 
to obtain information concerning presence and extend of infection. 
The early and reliable diagnosis is essential. Commonly, in daily 
clinical practice the diagnosis of VGI is based on contrast enhanced 
CT or MR, blood cultures and biochemical analysis. Sometimes, 
however, these procedures are inconclusive, especially in low-grade 
infections where a sensitivity and specificity of CT are about 55% 
and 100% [42], so more physiological approach is needed [43]. 
As in other inflammatory cases, increased FDG uptake is seen in 
VGI in areas of activated granulocytes [44]. Typically, in infected 
grafts focal and high uptake of FDG is observed over the pros-
thesis (Figure 5), whereas mild or sometimes quite high but linear 
activity along the grafts is rather related with inflammation after 
surgery or reaction of the body to foreign material (Figure 6). The 
appearance of the latter is related with false positive results [44]. 
The most difficult in the diagnosis and with highest mortality 
and morbidity rate are the complications associated with vascular 
prostheses in the chest. Tokuda et al. proposed the cut-off value 
of FDG uptake in thoracic aorta prosthesis (SUV max > 8) provid-
ing maximal sensitivity and specificity for differentiation between 
infected and non-infected graft (sensitivity: 1.0 and specificity: 
0.8) [43]. Figure 7 presents examples of thoracic aorta prosthe-
sis complicated by infections one month after implantation. For 
evaluation of VGI, most authors compare FDG uptake in prosthe-
sis with surrounding tissue [45–47]. Inter alia, Fukuchi et al. applied 
A B
Figure 4. Inflammation of the aortic abdominal aneurysm in a 65-year-old male patient. A. Fused 18FDG PET/CT, note high uptake of FDG (red 
arrow) in the aneurysm wall with small area of low uptake in left-lateral aspects of the aorta (parietal thrombus, yellow arrow); B. CT without contrast 
media of the same patient with fluid around the aortic abdominal aneurysms (blue arrow)
Figure 5. Infection of aorto-bi-iliac stent graft in a 76-year-old male 
patients, 3 years after implantation. Infection along the prosthesis, 
multiple abscesses in the abdomen, pelvis, groin and scrotum (white 
arrow). Active infection infiltrating the right psoas major muscle 
(red arrow). Aneurysm of the right common iliac artery with parietal 
thrombus (yellow arrow)
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Figure 6. The aorto-femoral prosthesis in a 61-year-old male patient, performed 6 months after replacement of silver salts inlaid prosthesis and 
implantation of biological prosthesis. No general signs or symptoms of infection were noted in this patients. A. 18F-FDG PET/CT showed quite high 
metabolic rate in prosthesis bilaterally (arrows); B. CT adapted from 18F-FDG PET/CT — inflammation reaction post biological graft implantation
A
B
Figure 7. A 36-year-old male patient, one month after Bentall procedure with sternotomy, with persistent fever and elevated biochemical markers 
of inflammation. A. High uptake of 18F-FDG in PET/CT coronal and sagittal slices (yellow arrows) in the mediastinum around the prosthesis of 
ascending aorta, without obvious uptake of FDG in prosthesis and in the aortic valve; B. High metabolic activity in sternum (white row) and in the 
lymph nodes (red arrow); C. Granulocyte antibody scintigraphy reveals lack of activity in bone marrow of the sternum (yellow arrow). Despite early 
post-surgery period, this feature, together with high uptake of 18F-FGD in that bone, suggests osteomyelitis and infections by continuance in the 
mediastinum; D. Contrast enhanced CT visualized dense fluid around the graft (yellow arrow), effusion in the left pleural cavity (white arrow)
A C
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a five-point scale, where grade 0 corresponds to FDG uptake in 
prosthesis similar to the background, grade 1 — FDG uptake in 
muscles and fat, grade 2 is defined as clearly visible, grade 3 
— strong FDG uptake, but lower than physiologic uptake in blad-
der, grade 4 — very strong — comparable with bladder. Grades 3 
and 4 were classified as infection. High sensitivity of 91–93% and 
specificity of 91–95% [45, 46], as well as high positive predictive 
value of 88% and negative predictive value of 96% were established 
for this method [46]. Bruggink et al. proved that single FDG-PET 
had better sensitivity 93%, specificity 70%, positive predictive value 
82% and negative predictive value 88% compared with CT: 56%, 
57%, 60% and 58%, respectively [48]. The authors also underline the 
influence of antibiotics therapy on detection of VGI, which is often 
very aggressive and may change well-detectable active infections in 
low-grade process and therefore produces false negative results, 
especially in single CT study. Vascular graft replacement is associ-
ated with higher false positive results [44].
Chronic periaortitis 
Chronic periaortitis (CP) is also known as retroperitoneal 
fibrosis or Ormond disease. It is an excessive fibro-inflammatory 
reaction, that starts in the adventitia of abdominal aorta and iliac 
arteries and extends into the retroperitoneum and also often leads to 
the involvement of adjacent structures (ureters, inferior vena cava). 
It is characterized by the presence of retroperitoneal and paraspinal 
fibrous mass [5]. This infiltration consists of fibroblasts, lympho-
cytes, macrophages and vascular endothelial cells [5]. Retroperi-
toneal fibrosis is commonly idiopathic, but also is associated with 
certain drugs, systemic disorders and malignant diseases. Chronic 
periaortitis includes three main entities: idiopathic retroperitoneal 
fibrosis (IRF), inflammatory abdominal aortic aneurysms (IAAAs), 
and perianeurysmal retroperitoneal fibrosis (PRF) [49–52]. Figure 8 
presents PRF in female patient with recurrent urinary tract infec-
tions and periodontal infections, which was presumed as a trig-
gering factor of the disease.
The signs of inflammation with increased levels of inflammatory 
markers are present in the clinical picture. CP is often linked with 
immunologic disease, such as systemic vasculitis [53]. Idiopathic 
retroperitoneal fibrosis is considered as an excessive inflamma-
tory response to atheromatic plaque antigens, such as oxidized 
low-density lipoproteins and ceroid [50, 52, 54]. Salvarani et al. 
[52] applied 18F-FGD PET/CT for detection of presence and extent 
of a large-vessel inflammation in patients with CP. The authors ob-
served seven patients with CP during 3 years. The increased ac-
cumulation of FDG indicated the inflammatory process, mainly 
localized in the abdominal aorta and/or in the common iliac arter-
ies. In 43% of the patients thoracic aorta and branches were also 
involved. FDG findings were similar to GCA and TA. According to 
the authors, the data suggest that CP may represent a large-vessel 
vasculitis involving the abdominal aorta and common iliac arteries, 
which in some patients also extends to the thoracic aorta and/or 
its branches [52]. 
A
B
Figure 8. Chronic periaortitis in a 65-year-old female patient with recurrent urinary tract infections and periodontal infections. A. FDG PET/CT before 
therapy. High uptake of FDG in the tissue around the aneurysm (SUV max 8); B. FDG PET/CT only after reducing sources of infections (tooth 
extraction, DJ renal catheter). Decreased uptake of FDG around the aneurysm (SUV max 5)
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Conclusions
In our review we stress the feasibility and value of 18F-FDG 
PET in vascular inflammation/infection depiction. The whole-body 
18F-FDG PET/CT imaging is an important, non-invasive, reliable 
diagnostic tool used in detecting and monitoring of infections and 
inflammations in vascular system. This method allows for im-
mediate assessment of response of anti-inflammatory treatment 
and guides a therapy. It is obvious that contemporary imaging of 
infections or inflammation, especially using FDG requires involving 
hybrid modalities. 
We do believe that in each case of problematic diagnosis of 
vascular infection or inflammation FDG imaging of activated leu-
cocytes brings an added value. For proper diagnosis of vascular 
infections, a diagnostic team should include a nuclear medicine 
physician, a radiologist and a vascular surgeon. Obviously, the 
final decision depends on the results of bacteriological and histo-
pathological examinations. 
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